These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 19023896)

  • 1. Mucocutaneous manifestations in inflammatory bowel disease.
    Yüksel I; Başar O; Ataseven H; Ertuğrul I; Arhan M; Ibiş M; Dağli U; Demirel BT; Ulker A; Seçilmiş S; Saşmaz N
    Inflamm Bowel Dis; 2009 Apr; 15(4):546-50. PubMed ID: 19023896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extraintestinal manifestations in inflammatory bowel disease: Prevalence and predictors in Indian patients.
    Bandyopadhyay D; Bandyopadhyay S; Ghosh P; De A; Bhattacharya A; Dhali GK; Das K
    Indian J Gastroenterol; 2015 Sep; 34(5):387-94. PubMed ID: 26614005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucocutaneous manifestations of inflammatory bowel disease in Turkey.
    Topaloğlu Demir F; Kocatürk E; Yorulmaz E; Adalı G; Kavala M
    J Cutan Med Surg; 2014 Nov; 18(6):397-404. PubMed ID: 25348761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucocutaneous manifestations of inflammatory bowel disease in central China -a single-centre study.
    Kou CX; Zhang YY; Li GW; Li J; Kong QT; Chen J; Liu F; Zhang M; Wang FY; Jiang Y; Hao LY; Ren JA; Sang H
    J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):e211-e212. PubMed ID: 29194792
    [No Abstract]   [Full Text] [Related]  

  • 5. Peripheral arthritis in the course of inflammatory bowel diseases.
    Yüksel I; Ataseven H; Başar O; Köklü S; Ertuğrul I; Ulker A; Dağlı U; Saşmaz N
    Dig Dis Sci; 2011 Jan; 56(1):183-7. PubMed ID: 20458624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease.
    Ampuero J; Rojas-Feria M; Castro-Fernández M; Cano C; Romero-Gómez M
    J Gastroenterol Hepatol; 2014 Feb; 29(2):291-5. PubMed ID: 23927379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].
    Kujundzić M
    Acta Med Croatica; 2013 Apr; 67(2):195-201. PubMed ID: 24471303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical manifestations of pyoderma gangrenosum associated with inflammatory bowel disease.
    Menachem Y; Gotsman I
    Isr Med Assoc J; 2004 Feb; 6(2):88-90. PubMed ID: 14986464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients.
    Veloso FT; Carvalho J; Magro F
    J Clin Gastroenterol; 1996 Jul; 23(1):29-34. PubMed ID: 8835896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous manifestations in inflammatory bowel disease.
    Tromm A; May D; Almus E; Voigt E; Greving I; Schwegler U; Griga T
    Z Gastroenterol; 2001 Feb; 39(2):137-44. PubMed ID: 11253504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extra-Gastrointestinal Manifestations of Inflammatory Bowel Disease May Be Less Common Than Previously Reported.
    Card TR; Langan SM; Chu TP
    Dig Dis Sci; 2016 Sep; 61(9):2619-26. PubMed ID: 27193564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extraintestinal Manifestations in Vedolizumab and Anti-TNF-Treated Patients With Inflammatory Bowel Disease.
    Dubinsky MC; Cross RK; Sandborn WJ; Long M; Song X; Shi N; Ding Y; Eichner S; Pappalardo B; Ganguli A; Wang A
    Inflamm Bowel Dis; 2018 Aug; 24(9):1876-1882. PubMed ID: 29668916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and Characteristics of Extra-intestinal Manifestations in a Large Cohort of Greek Patients with Inflammatory Bowel Disease.
    Karmiris K; Avgerinos A; Tavernaraki A; Zeglinas C; Karatzas P; Koukouratos T; Oikonomou KA; Kostas A; Zampeli E; Papadopoulos V; Theodoropoulou A; Viazis N; Polymeros D; Michopoulos S; Bamias G; Kapsoritakis A; Karamanolis DG; Mantzaris GJ; Tzathas C; Koutroubakis IE
    J Crohns Colitis; 2016 Apr; 10(4):429-36. PubMed ID: 26721936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.
    Bernstein CN; Blanchard JF; Rawsthorne P; Yu N
    Am J Gastroenterol; 2001 Apr; 96(4):1116-22. PubMed ID: 11316157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermatologic manifestations in inflammatory bowel disease in Tunisia.
    Mebazaa A; Aounallah A; Naija N; Cheikh Rouhou R; Kallel L; El Euch D; Boubaker J; Mokni M; Filali A; Ben Osman A
    Tunis Med; 2012 Mar; 90(3):252-7. PubMed ID: 22481199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and prevalence of extraintestinal manifestations in a cohort of patients with inflammatory intestinal disease in Medellin, Colombia.
    Juliao-Baños F; Arrubla M; Osorio L; Camargo J; Londoño J; Cáceres C; Carvajal J; Mosquera-Klinger G; Donado J
    Gastroenterol Hepatol; 2021; 44(6):398-404. PubMed ID: 33172691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Risk of Later Diagnosis of Inflammatory Bowel Disease in Patients With Dermatological Disorders Associated With Inflammatory Bowel Disease.
    King D; Chandan JS; Thomas T; Nirantharakumar K; Reulen RC; Adderley NJ; Trudgill N
    Inflamm Bowel Dis; 2021 Oct; 27(11):1731-1739. PubMed ID: 34669933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyoderma Gangrenosum in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    States V; O'Brien S; Rai JP; Roberts HL; Paas M; Feagins K; Pierce EJ; Baumgartner RN; Galandiuk S
    Dig Dis Sci; 2020 Sep; 65(9):2675-2685. PubMed ID: 31925675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort.
    Vavricka SR; Rogler G; Gantenbein C; Spoerri M; Prinz Vavricka M; Navarini AA; French LE; Safroneeva E; Fournier N; Straumann A; Froehlich F; Fried M; Michetti P; Seibold F; Lakatos PL; Peyrin-Biroulet L; Schoepfer AM
    Inflamm Bowel Dis; 2015 Aug; 21(8):1794-800. PubMed ID: 26020601
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.